Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells.
about
Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Targeting FLT3 in acute myeloi ...... n receptor-engineered T cells.
@en
Targeting FLT3 in acute myeloi ...... n receptor-engineered T cells.
@nl
type
label
Targeting FLT3 in acute myeloi ...... n receptor-engineered T cells.
@en
Targeting FLT3 in acute myeloi ...... n receptor-engineered T cells.
@nl
prefLabel
Targeting FLT3 in acute myeloi ...... n receptor-engineered T cells.
@en
Targeting FLT3 in acute myeloi ...... n receptor-engineered T cells.
@nl
P2093
P2860
P1476
Targeting FLT3 in acute myeloi ...... n receptor-engineered T cells.
@en
P2093
Haiyan Xing
Jianxiang Wang
Kejing Tang
Yanyan Xing
P2860
P2888
P356
10.1186/S13045-018-0603-7
P577
2018-05-02T00:00:00Z
P6179
1103752515